OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 75
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial
Ruihao Huang, Xiaoqi Wang, Hongju Yan, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Ruihao Huang, Xiaoqi Wang, Hongju Yan, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy
Megan Yuan, Wenjun Wang, Isobel Hawes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Megan Yuan, Wenjun Wang, Isobel Hawes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du, et al.
Nature Reviews Materials (2024)
Closed Access | Times Cited: 7
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du, et al.
Nature Reviews Materials (2024)
Closed Access | Times Cited: 7
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 6
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 6
Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation
Maria Elisabeth Kalland, Tomás Pose‐Boirazian, Gloria M. Palomo, et al.
Gene Therapy (2024) Vol. 31, Iss. 7-8, pp. 366-377
Open Access | Times Cited: 5
Maria Elisabeth Kalland, Tomás Pose‐Boirazian, Gloria M. Palomo, et al.
Gene Therapy (2024) Vol. 31, Iss. 7-8, pp. 366-377
Open Access | Times Cited: 5
Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges
Jun Kong, Mohammad Auwal Sa’ad, Hema Manusri Vijayan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Jun Kong, Mohammad Auwal Sa’ad, Hema Manusri Vijayan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner
Miao Zeng, Wei Zhang, Yisheng Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Miao Zeng, Wei Zhang, Yisheng Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer
Hany E. Marei, Khaled Bedair, Anwarul Hasan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Hany E. Marei, Khaled Bedair, Anwarul Hasan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Carbonic anhydrase 2-derived drug-responsive domain regulates membrane-bound cytokine expression and function in engineered T cells
Mara C. Inniss, Sean G. Smith, Dan Jun Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Mara C. Inniss, Sean G. Smith, Dan Jun Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201
Yuan Li, Sini Li, Yixiang Zhu, et al.
EBioMedicine (2025) Vol. 112, pp. 105515-105515
Open Access
Yuan Li, Sini Li, Yixiang Zhu, et al.
EBioMedicine (2025) Vol. 112, pp. 105515-105515
Open Access
Therapeutic role of immune cells against colon cancer
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access
Exploring CAR-PBMCs: A Novel Strategy Against EGFR-Positive Tumor Cells
Alexandru Tîrziu, Oana-Isabella Gavriliuc, Florina Bojin, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 264-264
Open Access
Alexandru Tîrziu, Oana-Isabella Gavriliuc, Florina Bojin, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 264-264
Open Access
Differentiating Induced Pluripotent Stem Cells into Natural Killer Cells for Adoptive Cell Immunotherapies—Comparative Characterization of Current Protocols
Tatiana Budagova, Anna Efremova, Natalia Usman, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1107-1107
Open Access
Tatiana Budagova, Anna Efremova, Natalia Usman, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1107-1107
Open Access
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy
Yishen Tian, Jingxuan Li, Na Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101545-101545
Open Access
Yishen Tian, Jingxuan Li, Na Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101545-101545
Open Access
Optical-magnetic Imaging for Optimizing Lymphodepletion-TIL Combination Therapy in Breast Cancer
Jiaqian Li, Lishuang Guo, Yuan Feng, et al.
Molecular Imaging and Biology (2025)
Closed Access
Jiaqian Li, Lishuang Guo, Yuan Feng, et al.
Molecular Imaging and Biology (2025)
Closed Access
Artificial cell-derived vesicles by extrusion, a novel docetaxel drug delivery system for lung cancer.
Javiera Carrasco-Rojas, Gabriela Zavala, Rafaël Contreras, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106693-106693
Closed Access
Javiera Carrasco-Rojas, Gabriela Zavala, Rafaël Contreras, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106693-106693
Closed Access
Mapping the landscape of gastric cancer immunotherapy: Bibliometric insights into advances and hotspots
Zhen Yuan, Jing-Hang Wang, Hao Cui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
Zhen Yuan, Jing-Hang Wang, Hao Cui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
